Skip to main content

Advertisement

SpringerLink
Log in

Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy

  • Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

To evaluate the efficacy of two prophylactic schemes for prostate biopsy using a single dose of oral levofloxacin given either before, or immediately after transrectal ultrasound-guided prostate biopsy.

Materials and methods

A total of 300 men formed two groups of 150 patients each: the first group received one dose of 500 mg of levofloxacin 30 min to an hour before, and the second group the same antibiotic immediately after prostate biopsy. No pre-biopsy enema was used. Side effects after prostate biopsy were recorded, and the two groups were compared.

Results

Only one patient from the first group developed a urinary tract infection after biopsy. A mean number of more than 10 cores per patient were taken. Haematuria was the most common complaint, followed by haemospermia. Haematuria and rectal bleeding were more common in patients where more than 8 cores were taken from the prostate (P = 0.005 and P = 0.017, respectively). Prostate cancer was detected in 34.3% of patients in total.

Conclusion

The use of a single dose of 500 mg levofloxacin given immediately after prostate biopsy proved to be quite effective for the prevention of infectious complications, even in the setting of an extensive biopsy protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schmid HP, Prikler L, Sturgeon CM et al (2003) Diagnosis of prostate cancer—the clinical use of prostate specific antigen. EAU Update Series 1:3–8

    Article  Google Scholar 

  2. Astraldi A (1937) Diagnosis of cancer of the prostate; biopsy by rectal route. Urol Cutan Rev 41:421–427

    Google Scholar 

  3. Binsaleh S, Al-Assiri M, Aronson S et al (2004) Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? Can J Urol 11(4):2352–2353

    PubMed  Google Scholar 

  4. Borer A, Gilad J, Sikuler E et al (1999) Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 38(2):128–129

    Article  PubMed  CAS  Google Scholar 

  5. Meisel F, Jacobi C, Kollamr R et al (2003) Acute meningitis after transrectal prostate biopsy. Urologe A 42(12):1611–1615

    Article  PubMed  CAS  Google Scholar 

  6. Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5,802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826–830

    Article  PubMed  Google Scholar 

  7. Sieber PR, Rommel FM, Agusta VE et al (1997) Antibiotic prophylaxis in ultrasound guide transrectal prostate biopsy. J Urol 157:2197–2200

    Article  Google Scholar 

  8. Carey JM, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 66:82–85

    Google Scholar 

  9. Jeon SS, Woo SH, Hyun JH et al (2003) Bisacodyl can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology 62(3):461–466

    Article  PubMed  Google Scholar 

  10. Shandera KC, Thibault GP, Deshon GE Jr (1998) Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 52:641–643

    Article  PubMed  CAS  Google Scholar 

  11. Griffith BC, Morey AF, Ali-Khan MM (2002) Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168:1021–1023

    Article  PubMed  CAS  Google Scholar 

  12. Aus G, Ahlgren G, Bergdahl S et al (1996) Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 77:851–855

    PubMed  CAS  Google Scholar 

  13. Cooner WH, Mosley BR, Rutherford CL Jr et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal exam and prostate specific antigen. J Urol 143:1146–1154

    PubMed  CAS  Google Scholar 

  14. Rodriguez LV, Terris MK (1998) Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160:2115–2120

    Article  PubMed  CAS  Google Scholar 

  15. Desmond PM, Clark J, Thompson IM et al (1993) Morbidity with contemporary prostate biopsy. J Urol 150:1425–1426

    PubMed  CAS  Google Scholar 

  16. Brewster SF, Macgowan AP, Gingell JC (1994) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol 76:351–354

    Article  Google Scholar 

  17. Vallancien G, Prapotnich D, Veillon B et al (1991) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146:1308–1312

    PubMed  CAS  Google Scholar 

  18. Enlund AL, Varenhorst E (1997) Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 79:777–780

    PubMed  CAS  Google Scholar 

  19. Isen K, Kupeli B, Sinik Z et al (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomised study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31:491–495

    Article  PubMed  CAS  Google Scholar 

  20. Cormio L, Berardi B, Callea A et al (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs. piperacillin/tazobactam. BJU Int 90:700–702

    Article  PubMed  CAS  Google Scholar 

  21. Shandera KC, Thibault GP, Deshon Jr GE (1998) Variability in patient preparation for prostate biopsy among American urologists. Urology 52:644–646

    Article  PubMed  CAS  Google Scholar 

  22. Davis M, Sofer M, Kim SS et al (2002) The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 167:566–570

    Article  PubMed  Google Scholar 

  23. Taylor HM, Bingham JB (1997) The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radiol 52:787–790

    Article  PubMed  CAS  Google Scholar 

  24. Drusano GL, Preston SL, Van Guilder M et al (2000) A population pharmakokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 44:2046–2051

    Article  PubMed  CAS  Google Scholar 

  25. Kapoor DA, Klimberg IW, Malek GH et al (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52:552–558

    Article  PubMed  CAS  Google Scholar 

  26. Peyromaure M, Ravery V, Messas S (2002) Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J Urol 167:218–221

    Article  PubMed  Google Scholar 

  27. Aron M, Rajeev J, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685

    Article  PubMed  CAS  Google Scholar 

  28. Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45:2–12

    Article  PubMed  CAS  Google Scholar 

  29. Hodge KK, McNeal JE, Terris MK (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74

    PubMed  CAS  Google Scholar 

  30. de la Taille A, Antiphon P, Salomon L et al (2003) Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 61:1181–1186

    Article  Google Scholar 

  31. Brown RW, Warner JJ, Turner BI et al (1981) Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 18:145–148

    Article  PubMed  CAS  Google Scholar 

  32. Lindert KA, Kabalin JN Terris MK (2000) Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164:76–80

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Athens General Hospital “G. GENNIMATAS”, Mesogion avenue, 11527, Athens, Greece

    Athanasios N. Argyropoulos, Konstantinos Doumas, Antonios Farmakis, Ioannis Liakatas, Ioannis Gkialas & Michael Lykourinas

Authors
  1. Athanasios N. Argyropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Konstantinos Doumas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonios Farmakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ioannis Liakatas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ioannis Gkialas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Lykourinas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Athanasios N. Argyropoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Argyropoulos, A.N., Doumas, K., Farmakis, A. et al. Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy. Int Urol Nephrol 39, 897–903 (2007). https://doi.org/10.1007/s11255-006-9112-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-9112-7

Keywords

Search

Navigation